Serotonergic drugs--a possible role in the treatment of psoriasis?

Drug News Perspect. 2007 Oct;20(8):521-5. doi: 10.1358/dnp.2007.20.8.1157614.

Abstract

Psoriasis is a chronic inflammatory skin disease, where specific immunity and/or innate immunity may be of importance in the disease pathogenesis. Psoriasis may be worsened by stress, which suggests that a neuroimmune interaction is contributing to the disease. Serotonin (5-HT) is a monoamine which besides general effects also has an impact on cell proliferation, migration and apoptosis. 5-HT exerts its effects via several receptors. 5-HT has a role in inflammation, and 5-HT receptors as well as its transporter protein have been found in psoriatic skin. 5-HT 1A receptor-positive mast cells, and 5-HT 2A receptor and serotonin reuptake transporter (SERT)-positive T lymphocytes may be targets for therapy with serotonergic drugs in psoriasis.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Models, Biological
  • Psoriasis / drug therapy*
  • Psoriasis / metabolism
  • Psoriasis / physiopathology
  • Receptors, Serotonin / metabolism
  • Serotonin / physiology
  • Serotonin Agents / pharmacology
  • Serotonin Agents / therapeutic use*

Substances

  • Receptors, Serotonin
  • Serotonin Agents
  • Serotonin